PDF
(Download)
|
- Cinnamon (Cinnamomum verum, Lauraceae)
- Cardamom (Elettaria cardamomum var. cardamomum, Zingiberaceae)
- Saffron (Crocus sativus, Iridaceae)
- Ginger (Zingiber officinale, Zingiberaceae)
- Type 2 Diabetes
- Glycemic Control
- Lipid Profile
|
Date:
04-15-2016 | HC# 091523-542
|
Re: Cinnamon and Ginger May Decrease Inflammation in Patients with Type 2 Diabetes
Azimi
P, Ghiasvand R, Feizi A, Hariri M, Abbasi B. Effects of cinnamon, cardamom, saffron, and ginger consumption on markers
of glycemic control, lipid profile, oxidative stress, and inflammation in type
2 diabetes patients. Rev Diabet
Stud. Fall-Winter 2014/15;11(3-4):258-266.
Type
2 diabetes (T2D) has increased in prevalence over the last 2 decades and is the
fourth leading cause of death in developed countries. T2D and several other
chronic diseases, including metabolic syndrome and heart disease, are
characterized by high levels of oxidative stress and inflammation. A number of plants,
including cinnamon (Cinnamomum verum,
Lauraceae), cardamom (Elettaria
cardamomum var. cardamomum, Zingiberaceae),
saffron (Crocus sativus, Iridaceae), and
ginger (Zingiber officinale, Zingiberaceae),
contain compounds that are strong antioxidants and anti-inflammatories. In
vitro and in vivo studies have shown that herbal medications containing these
plants can reduce oxidative stress and inflammation. In addition, these herbal
medications have sometimes been shown to alter glycemic control and lipid
profile. The goal of this randomized, controlled, single-blind study was to
measure the effect of teas made with cinnamon, cardamom, saffron, and ginger on
glycemic control, inflammation, oxidative stress, and lipid profile in patients
with T2D.
Patients
with T2D over the age of 29 were recruited from the Endocrine and Metabolism
Research Center at Isfahan University of Medical Sciences in Isfahan, Iran.
Patients were included if they were overweight (body mass index ≥ 25 kg/m2),
had fasting blood glucose concentrations ≥ 126 mg/dl, and were not taking
insulin. Patients could be taking the oral hypoglycemic medications
glibenclamide or metformin. Patients were excluded if they were pregnant,
needed to begin insulin therapy during the study, or consumed the study spices
as part of their regular diet.
The
study consisted of a 3-week run-in phase in which all patients drank a
consistent amount of black tea (Camellia
sinensis, Theaceae) each day. This was followed by an 8-week treatment
phase in which 3 cups of black tea (Golestan, Inc.; Tehran, Iran) were consumed
each day combined with 1 of the 4 powdered treatment herbs or without herbs
(control). The treatments consisted of 3 g of cardamom seeds, 3 g of ginger
rhizome, 3 g cinnamon bark, or 1 g saffron stigmas. No information was provided
on the origin of the herbs. Patients were divided randomly and almost evenly
among the groups (sample size varied between 39 and 42 patients). Patients
received packets of herbs and tea each week for the 8 weeks of the study and
were trained to stew the herbs and/or black tea for 10 minutes. Compliance and
adverse reactions were assessed each week.
Patients
were asked to maintain their regular activity level and diet for the duration
of the study. The following blood measurements were made at baseline and 8
weeks: fasting blood glucose, glycated hemoglobin (HbA1c), triglycerides (TG),
total cholesterol, low-density lipoproteins (LDL), high-density lipoproteins
(HDL), high-sensitivity C-reactive protein (hs-CRP), and F2-isoprostane.
Height, weight, and waist circumference also were measured at baseline and 8
weeks. Data were analyzed with one-way multivariate analysis of variance, Dunnett's
post hoc pairwise comparisons, and paired samples t-tests.
Four
of the 208 patients were excluded from analysis because a blood sample was not
obtained at the end of the study. At baseline, the saffron group was
significantly older and more overweight (P = 0.02 and 0.005, respectively).
There were no significant changes in anthropometric measures with time or
treatment. The ginger treatment resulted in a decrease in hs-CRP and
F2-isoprostane levels from the beginning to the end of the study (P = 0.04 and
0.01, respectively). The cinnamon treatment resulted in a decrease in hs-CRP,
fasting blood glucose, and TG from the beginning to the end of the study (P =
0.04, 0.003, and 0.02, respectively). In addition, significant treatment effects
among groups were found for total cholesterol, LDL, and HDL (P = 0.004, 0.01, and
0.001, respectively), compared to control. Cholesterol decreased in the
control, saffron, and ginger groups and increased in the cinnamon group. LDL
decreased in the cinnamon, saffron, ginger, and control groups. HDL decreased
in the saffron group and increased in the ginger and control groups. While none
of these changes from baseline values were significant, they did approach
significance (all P < 0.1). No adverse effects were reported.
Both
cinnamon and ginger steeped with black tea resulted in a decrease in the hs-CRP
biomarker of inflammation in overweight patients with T2D. In addition,
cinnamon in black tea resulted in a decrease in fasting blood glucose and TG,
while ginger reduced the oxidative stress marker F2-isoprostane. Significant
treatment effects were found for total cholesterol, LDL, and HDL, but in each
of these measures the improvement was similar or greater in the control group
when compared to most of the treatment groups. Each of the treatments,
cinnamon, cardamom, saffron, and ginger, has been previously shown to decrease
oxidative stress and inflammation. In this study, only ginger and cinnamon
reduced the marker for inflammation. In addition, other studies have found that
cinnamon may also alter glucose metabolism and blood lipid profile. The study may
have been limited by the lack of double blinding. It also may have been useful
to continue the duration of the study for longer than 8 weeks.
―Cheryl
McCutchan, PhD
|